h-header

news

News dal mondo

20

Apr

US GDUFA III: Use MDUFA model to create competition in generic drug markets

To design an effective financing system for generic drug approvals, the FDA must balance the need to ensure sustainability with the goal of providing a level playing field for competition among firms of all sizes. To this end, the agency should impose fees where they are least likely to discourage supply...[HealthAffairsBlog]

06

Mag

EDQM - New policy for the development of monographs on medicinal products containing chemically defined active substance salts or bases/acids

At its 169th session (March 2021), the European Pharmacopoeia (Ph. Eur.) Commission approved a new...

05

Mag

EU Draft report on a pharmaceutical strategy for Europe

Draft report on a pharmaceutical strategy for Europe [2021/2013(INI) – Rev. 26 aprile...

slider-banner

h-footer